Home  |  Press Releases  |  About Galil Medical  |  Investor Relations  |  Contacts  |  Customer Support

   

PROSTATE CANCER
CRYOTHERAPY

PROSTATE CANCER CRYOSURGERY

PROSTATE CANCER
STATISTICS

PATIENT CRITERIA

TECHNOLOGICAL
ADVANCES

Overview

Symptoms

Cryosurgery Procedures

Case Study

Publications / References

Clinical Sites / Studies

FAQs

KIDNEY CANCER
CRYOTHERAPY

IMAGE-GUIDED
CRYOABLATION

CRYOABLATION
TECHNOLOGY

CRYOABLATION
PRODUCTS

 

PROSTATE CANCER CRYOTHERAPY

Prostate Cancer Statistics in the United States

 

Prostate cancer is one of the most common cancers in American men. The American Cancer Society estimates that during 2007 more than 200,000 men will be diagnosed with prostate cancer. This translates to about one in six men being diagnosed with prostate cancer during his lifetime. According to the International Agency for Research on Cancer (IARC) estimates, there were 345,900 prostate cancer cases, with 87,400 deaths in the European Union in 2006. Worldwide prostate cancer statistics indicate that over 700,000 men annually will be diagnosed with prostate cancer. The older a man is, the greater the risk for him to be diagnosed with prostate cancer. To learn about more risk factors, see Who is at Risk?

Statistics for Prostate Cancer Survival Rates
Statistics of prostate cancer show prostate cancer to be the second leading cause of cancer death in American men. However, only a little more than 12% of men diagnosed with prostate cancer will die from it. Men with prostate cancer are more likely to die with the disease than from it. In fact, more than two million men in the United States who have given treatment for prostate cancer are still alive today.

Nine out of 10 prostate cancer cases are found in the local and regional prostate cancer stages. This means the cancer is still confined to the prostate or nearby organs and not to distant sites like the lungs. The five-year relative prostate cancer survival statistics rate for these men is 100%. Relative survival rates compare the survival rate for prostate cancer patients with that expected for men of the same age and race without prostate cancer. For men whose prostate cancer has reached distant parts of the body, the five-year relative survival rate decreases to 32%.

According to the most recent data, for all men with prostate cancer, the relative 10-year survival rate is 93% and the 15-year survival rate is 77%. Modern methods of detection mean that prostate cancers are now found earlier and treated more effectively. If you are diagnosed this year, your outlook is likely to be better than the numbers reported above.

Early Prostate Cancer Stages
If prostate cancer is detected early, when it is still confined to the prostate, there is a better chance of treatment success. This also allows for patients to have the choice of a minimally invasive surgery called cryotherapy ablation. Focal cryotherapy, for instance, is showing very promising signs of prostate cancer treatment while keeping treatment side effects to a minimum.

Advanced Prostate Cancer
Once prostate cancer has spread beyond the prostate to local areas, prostate cancer treatment options are still available. However, the risk of side effects such as impotence or incontinence rises. When prostate cancer becomes advanced and reaches distant organs of the body such as the bones, lungs or brain – the cancer becomes increasingly difficult to treat. See Treatment Success Rates for more detailed information about these statistics.

 
 
 

© 2007 Galil Medical. All rights reserved.
Site Map | Disclaimers—Terms of Use | Glossary | More Information | HIPPA | Employees | Physicians
Website Design by DDA Medical